NG2 cells, also known as oligodendrocyte progenitors or polydendrocytes, are a major component of the glial scar that forms after spinal cord injury. NG2 cells react to injury by proliferating around the lesion site and differentiating into oligodendrocytes and astrocytes, but the molecular mechanism is poorly understood. In this study, we tested the role of the transcription factor STAT3, and its suppressor SOCS3, in NG2 cell proliferation and differentiation after spinal cord injury. Using knockout mice in which STAT3 or SOCS3 are genetically deleted specifically in NG2 cells, we found that deletion of STAT3 led to a reduction in oligodendrogenesis, while deletion of SOCS3 led to enhanced proliferation of NG2 cells within the glial scar after spinal cord injury. Additionally, STAT3 and SOCS3 were not required for astrogliogenesis from NG2 cells after spinal cord injury. Interestingly, genetic deletion of STAT3 and SOCS3 did not have opposing effects, suggesting that SOCS3 may have targets other than the STAT3 pathway in NG2 cells after spinal cord injury. Altogether, our data show that both STAT3 and SOCS3 play important, yet unexpected, roles in NG2 cell proliferation and differentiation after spinal cord injury.
Introduction
Oligodendrocyte progenitor cells (OPCs), also known as NG2 cells, are capable of differentiating into oligodendrocytes in the developing and the adult CNS (Nishiyama et al., 2009) and comprise approximately 70% of all dividing cells in the adult spinal cord (Horner et al., 2000) . Although most studies focus on the role of NG2 cells in remyelination after spinal cord injury (SCI), less is known about their contribution to the glial scar (Levine, 2015; Son, 2015) . Several studies implicate their production of chondroitin sulfate proteoglycans (CSPGs) (Dou and Levine, 1994; Levine, 1994; Petrosyan et al., 2013; Tan et al., 2006) and capacity to form synapses with dystrophic axons (Filous et al., 2014) to be largely inhibitory for axon regeneration. In addition, NG2 cells react to injury in a similar manner to reactive astrocytes in that they become hypertrophic and proliferate in the penumbra surrounding the injury site (McTigue et al., 2001; Zai and Wrathall, 2005) . In fact, NG2 cells have been shown to differentiate into GFAP + astrocytes after several models of CNS injury (Komitova et al., 2011; Sellers et al., 2009; Tripathi et al., 2010; Zawadzka et al., 2010) . However, the signaling pathways involved in the proliferation and differentiation of NG2 cells after SCI are not well understood. Cytokines such as CNTF and LIF have been suggested to be important for NG2 cell proliferation and differentiation into oligodendrocytes and astrocytes in vitro as well as development of oligodendrocytes in vivo (Barres et al., 1996; Ishibashi et al., 2009; Mayer et al., 1994) . The best characterized signaling pathway for many of these cytokines is activation of the JAK-STAT3 pathway through the gp130 receptor. This pathway is negatively regulated by SOCS3, which binds to the gp130-JAK complex. Cytokine expression is increased in the glial scar region after contusive SCI (Tripathi and McTigue, 2008; Zai et al., 2005) and high levels of phospho-STAT3, which is nearly undetectable in the uninjured spinal cord, are found in NG2 cells in this region (Hesp et al., 2015; Tripathi and McTigue, 2008) . The JAK-STAT3 signaling pathway has also been implicated in astrocyte differentiation from Nestin + cortical precursor cells due to the binding of STAT3 to the GFAP promoter (Bonni et al., 1997; Nakashima et al., 1999b) , and astrogliogenesis and oligodendrogenesis is impaired in LIF KO mice and gp130 KO mice (Bugga et al., 1998; Nakashima et al., 1999a) . Furthermore, both STAT3 and SOCS3 have been implicated in astroglial scar formation after SCI (Herrmann et al., 2008; Okada et al., 2006; Wanner et al., 2013) , but their role in NG2 cells after SCI is not known.
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Abbreviations: CNTF, Ciliary neurotrophic factor; CSPG, Chondroitin sulfate proteoglycan; DAPI, 4′,6-Diamidino-2-phenylindole; EdU, 5-Ethynyl-2′-deoxyuridine; GFAP, Glial fibrillary acidic protein; JAK, Janus kinase; LIF, Leukemia inhibitory factor; NG2, Neural glial antigen 2; OPC, Oligodendrocyte progenitor cell; SCI, Spinal cord injury; SOCS3, Suppressor of cytokine signaling 3; STAT3, Signal transducer and activator of transcription 3; TUNEL, Terminal deoxynucleotidyl transferase (TdT) dUTP nick-end labeling.
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